Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141811 |
| CAS No | NA |
| Mol.F. | C16H15N3O7 |
| Mol.Wt. | 361.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141812 |
| CAS No | NA |
| Mol.F. | C36H40N4O7 |
| Mol.Wt. | 640.7 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0141813 |
| CAS No | NA |
| Mol.F. | C35H36N4O7 |
| Mol.Wt. | 624.7 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141814 |
| CAS No | NA |
| Mol.F. | C36H40N4O7 |
| Mol.Wt. | 640.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141815 |
| CAS No | NA |
| Mol.F. | C22H22N8O2 |
| Mol.Wt. | 430.5 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141816 |
| CAS No | NA |
| Mol.F. | C11H19N3O3 |
| Mol.Wt. | 241.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141817 |
| CAS No | NA |
| Mol.F. | C6H10N4O2 |
| Mol.Wt. | 170.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141818 |
| CAS No | NA |
| Mol.F. | C6H10N2O5 |
| Mol.Wt. | 190.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141819 |
| CAS No | NA |
| Mol.F. | C28H34N4O9 |
| Mol.Wt. | 570.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141820 |
| CAS No | NA |
| Mol.F. | C20H20N4O2 |
| Mol.Wt. | 348.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141821 |
| CAS No | NA |
| Mol.F. | C20H21F3N4OS |
| Mol.Wt. | 422.g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0141822 |
| CAS No | NA |
| Mol.F. | C8H13N3OS |
| Mol.Wt. | 199.27 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141823 |
| CAS No | 80-11-5 |
| Mol.F. | C8H10N2O3S |
| Mol.Wt. | 214.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141824 |
| CAS No | NA |
| Mol.F. | C19H22N2O2 |
| Mol.Wt. | 310.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141825 |
| CAS No | NA |
| Mol.F. | C21H22N2O3 |
| Mol.Wt. | 350.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141826 |
| CAS No | NA |
| Mol.F. | C11H19N3O5 |
| Mol.Wt. | 273.29 |
| INV STATUS | In Stock |